Report overview
Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, significant progress has been made in the field of nano-medicine (i.e. nano-technology), resulting in a number of products, including therapeutics and imaging agents, enabling more effective and less toxic therapeutic and diagnostic interventions.
This report contains market size and forecasts of Nanotechnology Drug Delivery in Global, including the following market information:
Global Nanotechnology Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nanotechnology Drug Delivery market was valued at 6153.4 million in 2021 and is projected to reach US$ 9741.5 million by 2028, at a CAGR of 6.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nanocrystals Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nanotechnology Drug Delivery include AbbVie, Amgen, Celgene, Johnson & Johnson, Merck & Co., Novartis International, Perrigo Company, Pfizer and Teva Pharmaceutical Industries. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nanotechnology Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nanotechnology Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nanotechnology Drug Delivery Market Segment Percentages, by Type, 2021 (%)
Nanocrystals
Nanoparticles
Liposomes
Micelles
Nanotubes
Others
Global Nanotechnology Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nanotechnology Drug Delivery Market Segment Percentages, by Application, 2021 (%)
Neurology
Oncology
Cardiovascular/Physiology
Anti-inflammatory/Immunology
Anti-infective
Others
Global Nanotechnology Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nanotechnology Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nanotechnology Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Nanotechnology Drug Delivery revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Celgene
Johnson & Johnson
Merck & Co.
Novartis International
Perrigo Company
Pfizer
Teva Pharmaceutical Industries
